Laporan Laba Rugi (TTM)
Laporan Laba Rugi Algorae Pharmaceuticals Limited - Equity Warrant menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | -12.20 | -19.06 | -23.54 | -21.03 | -26.64 | -48.90 | -95.71 | 0.00 | 0.00 | -50.01 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | -0 | -1 | -0 | -0 | -1 | -0 | |||||
| Change (%) | 100.00 | -50.00 | 100.00 | -50.00 | |||||||
| % of Revenue | -55.56 | -126.56 | -78.18 | -160.63 | -437.89 | -428.50 | |||||
| Gross Operating Profit | 1 | 1 | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Change (%) | 27.88 | -36.34 | -57.09 | 105.81 | 51.41 | -49.80 | -99.19 | 0.00 | 0.00 | -50.01 | |
| % of Revenue | 155.56 | 226.56 | 178.18 | 100.00 | 260.63 | 537.89 | 528.50 | 100.00 | 100.00 | 100.00 | 100.00 |
| SG&A | 0 | 0 | 0 | ||||||||
| Change (%) | 100.00 | 32.29 | |||||||||
| % of Revenue | 1,901.06 | 3,802.09 | 10,062.34 | ||||||||
| R&D | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 |
| Change (%) | 0.00 | -16.25 | -19.40 | 18.82 | 15.84 | -16.97 | -20.44 | 11.06 | 9.96 | -13.39 | |
| % of Revenue | 483.03 | 550.12 | 569.21 | 600.05 | 902.90 | 1,425.67 | 2,316.60 | 42,970.16 | 47,722.82 | 52,475.48 | 90,926.56 |
| OpEx | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 1 | 2 | 2 | 2 |
| Change (%) | -13.89 | -5.36 | -5.66 | -2.32 | -2.37 | -2.33 | -2.39 | 15.48 | 13.41 | -10.30 | |
| % of Revenue | 424.12 | 415.94 | 486.32 | 600.05 | 742.27 | 987.78 | 1,888.11 | 42,970.16 | 49,623.85 | 56,277.56 | 100,988.95 |
| Operating Income | -2 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -2 | -2 |
| Change (%) | -14.41 | -1.02 | -1.03 | 1.43 | 1.41 | 2.91 | 2.83 | 15.52 | 13.44 | -10.23 | |
| % of Revenue | -324.12 | -315.94 | -386.32 | -500.05 | -642.27 | -887.78 | -1,788.11 | -42,870.16 | -49,523.85 | -56,177.56 | -100,888.90 |
| Interest Expense | -0 | -0 | -0 | -0 | -0 | -0 | |||||
| Change (%) | 100.00 | -0.00 | 99.97 | -0.00 | |||||||
| % of Revenue | -3.02 | -6.89 | -8.51 | -1.52 | -4.14 | -8.11 | |||||
| Net Income | -1 | -1 | -1 | -1 | -2 | -2 | -2 | -2 | -2 | -3 | -2 |
| Change (%) | 17.73 | 2.69 | 2.62 | 3.10 | 3.01 | 13.09 | 11.58 | 14.63 | 12.76 | -8.34 | |
| % of Revenue | -238.54 | -319.84 | -405.77 | -544.62 | -711.07 | -998.37 | -2,209.72 | -57,483.11 | -65,890.10 | -74,297.12 | -136,236.08 |
Source: Capital IQ
